University Health Network, Toronto
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University Health Network, Toronto sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
University Health Network, Toronto: 23 sponsored US clinical trials, 6 recruiting.
University Health Network, Toronto sponsors 23 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 14 completed. 1 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Organ Preservation, with 1 trials.
Top-decile sponsor footprint
University Health Network, Toronto ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
23 total, page 1 of 1
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
NCT06442930
The STOP-MED CTRCD Trial
NCT06183437
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
NCT06050707
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
NCT05592938
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
NCT04016389
10°C vs 4°C Lung Preservation RCT
NCT05898776
Swallowing Impairment After COVID-19 Infection
NCT04537650
Pancreatic Adenocarcinoma Signature Stratification for Treatment
NCT04469556
Tongue Pressure Resistance Training for Swallowing Impairment Post-Stroke
NCT03969095
PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer
NCT03455608
Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
NCT03192358
Safety and Tolerability of Perampanel in Cervical Dystonia
NCT02131467
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
NCT02363738
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
NCT01954316
A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
NCT01672736
Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia
NCT01332786
Colorectal Cancer Screening for Cancer Survivors
NCT00982059
Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia
NCT00570557
Effects of Exemestane on Bone Strength
NCT01144468
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
NCT00066352
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
NCT00047216
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
NCT00045669
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 4 | 1 |
What is open in the University Health Network, Toronto pipeline
6 recruiting of 23 indexed (26% open); 14 completed (61%).
Phase mix: 1 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Organ Preservation (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University Health Network, Toronto: open-pipeline peers nationwide
Peers matched on 23 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
University Health Network, Toronto sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 trials (± recruiting share)
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- AtriCure · 23 trials · 22% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
Sponsors near 26% open enrollment (± trial volume)
- Shirley Ryan AbilityLab · 26% recruiting · 138 trials
- Syracuse University · 26% recruiting · 31 trials
- Rutgers, The State University of New Jersey · 26% recruiting · 413 trials
- Hackensack Meridian Health · 26% recruiting · 90 trials
Related
What to do with this University Health Network, Toronto page
23 registered trials is a research-attention snapshot, not an endorsement of University Health Network, Toronto or any single study.
- 6 of University Health Network, Toronto's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Organ Preservation is the condition University Health Network, Toronto studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Organ Preservation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University Health Network, Toronto pipeline card: 23 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.